Types and Epidemiology of Cancer-Related Neuropathic Pain: The Intersection of Cancer Pain and Neuropathic Pain
- 1 May 2010
- journal article
- review article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 15 (S2), 3-8
- https://doi.org/10.1634/theoncologist.2009-s505
Abstract
Neuropathic pain—pain resulting from a lesion, damage, or dysfunction of the somatosensory nervous system—can arise through several distinct etiologies ranging from toxicity, surgery, radiation, and trauma to congenital disorders. Neuropathic pain is widely recognized as a common consequence of cancer and results from administration of several common oncology drugs. It not only impacts quality of life, but it also impacts patient outcomes because of resulting treatment delays, dose reductions, and discontinuations. We estimate that the cost of the problem in the U.S. alone is approximately $2.3 billion. Despite its widely recognized importance, there is a paucity of reliable information available regarding the incidence, prevalence of patient-and physician-reported severity, and time course of cancer-related neuropathic pain. To address this severe knowledge gap, we need new, high-quality, population-based studies of individual cancer pain syndromes and conditions. However, in order to gather this information, we also need substantial improvements in the specific classification of cancer-related neuropathic syndromes and better validated diagnostic tools that can help to elucidate the incidence, prevalence, severity, and potential economic impact of cancer-associated neuropathies.Keywords
This publication has 9 references indexed in Scilit:
- Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02Supportive Care in Cancer, 2009
- A Questionnaire Survey of Physicians' Perspectives Regarding the Assessment of Chemotherapy-induced Peripheral Neuropathy in Patients with Breast CancerJapanese Journal of Clinical Oncology, 2008
- Neuropathic pain in cancerEuropean Journal of Cancer, 2008
- Neuropathic painNeurology, 2008
- Diagnosis, Management, and Evaluation of Chemotherapy-Induced Peripheral NeuropathySeminars in Oncology, 2006
- Evaluating the Total Costs of Chemotherapy-Induced Toxicity: Results from a Pilot Study with Ovarian Cancer PatientsThe Oncologist, 2001
- The Treatment of Cancer PainThe New England Journal of Medicine, 1985
- The natural history of lumbosacral plexopathy in cancerNeurology, 1985
- Brachial plexus lesions in patients with cancer=100 casesNeurology, 1981